Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose ICE Conditioning with ASCT for Recurrent Nasopharyngeal Carcinoma
NCT02137096Phase 3Terminated
- Sponsor
- University of Florida
- Start
- Jun 2014
- Primary completion
- May 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide phosphate, carboplatin, ifosfamide in nasopharyngeal carcinoma (NPC), sponsored by University of Florida. Started Jun 2014; status: terminated.
02
Drugs
etoposide phosphatecarboplatinifosfamide
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02137096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137096.